Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Net Income: 2022-2024

Historic Net Income for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to -$60.9 million.

  • Orchestra BioMed Holdings' Net Income fell 35.02% to -$20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.1 million, marking a year-over-year decrease of 33.72%. This contributed to the annual value of -$60.9 million for FY2024, which is 27.88% down from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Net Income is -$60.9 million, which was down 27.88% from -$47.7 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Net Income ranged from a high of -$32.7 million in FY2022 and a low of -$60.9 million during FY2024.
  • Over the past 3 years, Orchestra BioMed Holdings' median Net Income value was -$47.7 million (recorded in 2023), while the average stood at -$47.1 million.
  • Data for Orchestra BioMed Holdings' Net Income shows a maximum YoY plummeted of 45.93% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Net Income stood at -$32.7 million in 2022, then slumped by 45.93% to -$47.7 million in 2023, then dropped by 27.88% to -$60.9 million in 2024.